CAS 1067214-81-6

GSK7227

Description:

GSK7227, with the CAS number 1067214-81-6, is a chemical compound that has been studied primarily for its potential therapeutic applications. It is classified as a small molecule inhibitor, specifically targeting certain enzymes involved in cellular processes. The compound exhibits properties that may influence various biological pathways, making it of interest in drug development, particularly in the context of cancer research. GSK7227 has been evaluated for its efficacy in inhibiting tumor growth and modulating immune responses. Its chemical structure includes specific functional groups that contribute to its biological activity and solubility characteristics. As with many investigational compounds, the safety profile, pharmacokinetics, and mechanism of action are critical areas of study to determine its viability as a therapeutic agent. Ongoing research aims to elucidate its full potential and any associated side effects, contributing to the broader understanding of its role in medicinal chemistry.

Formula: C₂₅H₂₂N₂O₆S

Synonyms:

• Benzoic acid, 2-[[3-[(5-methoxy-4-methyl-1H-indol-1-yl)sulfonyl]benzoyl]amino]-5-methyl-
• GSK7227
• 2-(3-((5-Methoxy-4-methyl-1H-indol-1-yl)sulfonyl)benzamido)-5-methylbenzoic acid

GSK-7227

CAS: 1067214-81-6

GSK-7227

Purity: ≥98%

Molecular weight: 478.52g/mol

Ref: 54-BUP22214

GSK-7227

CAS: 1067214-81-6

GSK-7227 is a novel PPARδ partial agonist that upregulates target genes in muscle cells, indicating its potential role in modulating muscle metabolism and energy.

Formula: C₂₅H₂₂N₂O₆S

Purity: 99.17%

Color and Shape: Solid

Molecular weight: 478.52

Ref: TM-T27489